2 Mid-Cap Healthcare Stocks to Buy Now
These drugmakers are in the sweet spot to provide market-beating returns.
Agios Pharmaceuticals
AGIO
AGIO
$39.24
$1.06
2.8%
Price as of October 29, 2020, 8:00 p.m. EDT
View Interactive AGIO Charts
AGIOS PHARMACEUTICALS INC
Interactive Chart
News & Analysis: Agios Pharmaceuticals
Agios Pharmaceuticals Inc (AGIO) Q2 2020 Earnings Call Transcript
AGIO earnings call for the period ending June 30, 2020.
Got $1,000? Buy These 4 Cancer Stocks
These four cancer therapeutics stocks are poised to experience long-term growth. An investment in any of these today could bring huge rewards.
Agios Pharmaceuticals Inc (AGIO) Q1 2020 Earnings Call Transcript
AGIO earnings call for the period ending March 31, 2020.
Agios Pharmaceuticals Inc (AGIO) Q4 2019 Earnings Call Transcript
AGIO earnings call for the period ending December 31, 2019.
Agios Pharmaceuticals Raised $294 Million to Fight Cancer and Rare Genetic Diseases: What It Means for Investors
The cash will help the biotech get to profitability.
Agios Pharmaceuticals Inc (AGIO) Q3 2019 Earnings Call Transcript
AGIO earnings call for the period ending September 30, 2019.
Agios Pharmaceuticals Inc (AGIO) Q2 2019 Earnings Call Transcript
AGIO earnings call for the period ending June 30, 2019.
Agios Pharmaceuticals Inc (AGIO) Q1 2019 Earnings Call Transcript
AGIO earnings call for the period ending March 31, 2019.
Agios Pharmaceuticals Inc (AGIO) Q4 2018 Earnings Conference Call Transcript
AGIO earnings call for the period ending December 31, 2018.
